This paper reviews the treatment of psoriasis with mesenchymal stem cells. Because psoriasis is driven by immune dysfunction and chronic inflammation, MSC therapy offers a potential way to address the underlying biology rather than just managing symptoms.

For patients with psoriasis, this research highlights an emerging regenerative option that may complement or replace traditional treatments.

This is a research reference from our clinical library. Approved by the Chambers Clinic Team — last reviewed May 28, 2026.